A new study in GeroScience suggests that living longer and staying functional are not the same thing, at least in male roundworms. Researchers at the University of Oregon tested seven well-known pro-longevity compounds and found that every one extended male lifespan. Only two, sulforaphane and metformin, also preserved a measurable function late in life.
Important caveat up front: this is worm-only research. The experiments were done in Caenorhabditis elegans, a roundworm widely used in aging biology. Nothing here shows that these compounds extend lifespan or healthspan in humans, and nothing here is a basis for supplement or medication decisions.
What the researchers did
The study, led by Al-Saadi and Phillips at the Institute of Ecology & Evolution, University of Oregon, addresses a gap in aging research. Most compound screens in C. elegans have been run in hermaphrodites, the dominant sex in the species. Sex differences in aging are well documented across animals, yet the biology behind them, and whether interventions work equally in both sexes, remains understudied.
The team asked whether compounds known to extend hermaphrodite lifespan do the same in males. They tested seven compounds, each at two concentrations:
- Metformin
- Sulforaphane
- Resveratrol
- Propyl gallate
- All-trans retinoic acid
- Thioflavin T
- Gold sodium thiomalate
They measured two things: lifespan, and reproductive healthspan, assessed through mating success in late life.
Lifespan: a clean sweep
On lifespan, the result was uniform. Every compound extended male lifespan under every tested condition. That consistency is notable in itself. It suggests that many interventions identified in hermaphrodites translate to males, at least for the blunt endpoint of how long the animals live.
If lifespan were the only readout, the study would read as a straightforward success story for all seven compounds.
Healthspan: only two survive the cut
The picture changed when the researchers looked at late-life mating success. Male mating is a demanding behavior that requires coordinated neuromuscular function, sensory processing, and motivation. It makes a useful stand-in for how well an aging animal retains complex function, in this case reproductive healthspan.
Only two conditions improved late-life mating: sulforaphane and metformin. The other compounds extended life without improving this functional measure. In other words, those worms lived longer but did not mate better in old age.
The authors conclude that lifespan and healthspan can be decoupled in C. elegans males. Adding days to life does not guarantee that those added days are functional ones.
Why this matters for longevity screening
Aging research has increasingly stressed that the goal is not merely longer life but more years of healthy function. Many compound screens, particularly high-throughput ones in invertebrates, use lifespan as the primary readout because it is easy to measure. This study illustrates a risk of that approach: a compound can look like a winner on survival curves while doing little for function.
The authors position their work as a new framework for screening pro-longevity compounds. Adding a functional, behavior-based endpoint such as mating success could help separate interventions that merely prolong survival from those that preserve capacity.
Why sulforaphane and metformin?
The abstract does not explain the mechanism, so any explanation here is speculative. Both compounds have been studied widely in aging biology. Metformin is a common diabetes drug that has been linked to effects on cellular energy sensing and metabolism. Sulforaphane, a compound derived from cruciferous vegetables such as broccoli, is associated with stress-response and detoxification pathways. Whether these pathways explain the preserved mating performance in males is not established by this study, and the work does not test mechanisms.
It is also worth noting that the other five compounds are not shown to be useless. They extended lifespan, and the study measured only one healthspan proxy. Other functions, such as movement or stress resistance, might respond differently.
Limitations and context
- Worms, not humans. C. elegans is a powerful model, but its biology differs substantially from mammals. Results often fail to translate.
- Male-focused, single healthspan measure. Mating success captures reproductive and neuromuscular function, but it is not a complete picture of healthspan.
- Two concentrations per compound. Dose-response relationships were only coarsely explored.
- No mechanism. The study shows an association between compound and outcome, not the biological reason.
The paper is also an update of a 2025 bioRxiv preprint, now published after peer review, and the authors declare no competing interests.
The takeaway
The main message is conceptual rather than clinical. Lifespan extension and preserved function can come apart, and screening only for the former may overstate a compound's value. In male worms, sulforaphane and metformin stood out because they delivered both. Whether anything similar holds in mammals, or in people, is an open question that this study does not attempt to answer.
For now, the finding is best read as a methodological nudge to the longevity field: measure how well animals live, not just how long.